Expert explains what Ethiopia is hiding regarding the GERD
In a post on his Facebook account on Sunday, he explained that the water reached this level in the GERD lake upon the completion of the first filling on September 5, 2024.
After that, Ethiopia opened three gates to release excess water until they were completely closed on December 24, 2024.
The GERD's reservoir level dropped by only five billion cubic meters over a 10-month period (September 2024 – July 2025), while the power generation turbines were supposed to consume at least 30 billion cubic meters if operating at 50 percent efficiency.
However, the reservoir level remained unchanged until the onset of the rains on July 1, and then returned to full storage on Sunday.
'The inefficient operation of the turbines required a gradual release of water starting in April, but the gates were not opened to prevent the public from discovering that the turbines were not operating efficiently and remained closed,' the professor noted.
He said that, 'Two gates of the upper spillway must be opened to maintain the actual storage of 60 billion cubic meters, even though the lake can hold an additional four billion cubic meters at a level of 640 meters, the level of the middle spillway.'
The Egyptian expert did not rule out the possibility that Ethiopia would continue to store water until it reaches the middle spillway level.
In this case, the filling would be complete by the end of this month, given that the average flow in the coming days will range between 350 and 400 million m3/day.
Sharaky emphasized that Sudanese dams do not store water at the beginning of the season and their gates are currently open. Water was expected to be released from GERD starting on Sunday, if the spillway gates are opened, or from the top of the middle spillway on July 31.
He added that, 'In any case, the High Dam is ready to receive floodwater.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CairoScene
3 days ago
- CairoScene
Historic Maspero Studio Named After Nobel Prize Winner Ahmed Zewail
The National Media Authority honours Nobel Laureate Zewail with a studio in his name and initiatives in scientific media. Aug 04, 2025 Maspero's historic Studio 45 will be renamed after Dr Ahmed Zewail, as part of a push to revive scientific journalism and improve public understanding of science, according to National Media Authority (NMA) President Ahmed El-Meslamani. Alongside the renaming, NMA announced the launch of 'Kalam fi El-Elm' ('Talks in Science'), a television programme hosted by biophysicist Dr Sameh Saad Ali, founding director of the Center for Aging Studies at Zewail City of Science and Technology. Dr Ahmed Zewail received the 1999 Nobel Prize in Chemistry for breakthroughs in femtochemistry - the study of chemical reactions on extremely short timescales. He was the first Egyptian and first Arab to win the award. El-Meslamani also announced an upcoming national symposium, 'The Present and Future of Scientific Media in Egypt', organised by the Maspero Center for Media Studies in collaboration with the Cultural Channel and Cultural Radio Programme. He said the initiatives aim to make reliable, non-specialist scientific content more accessible to younger audiences.
Daily News Egypt
28-07-2025
- Daily News Egypt
Minapharm Majority Shareholder Triquera Partners with Admaius Capital to Drive Global Biotech Expansion
Triquera B.V., the majority shareholder of Egyptian biopharmaceutical leader Minapharm, has secured a minority investment from Admaius Capital Partners in a landmark deal aimed at accelerating the regional and global expansion of Minapharm's biotechnology footprint. Admaius, an Africa-focused private equity firm, joins forces with Triquera to support the continued growth of Minapharm, which operates one of the largest biological drug substance and product facilities in the Middle East and Africa. The company is renowned for its end-to-end capabilities in manufacturing complex recombinant proteins, viral vectors, and advanced biologics, with operations in both Cairo and Berlin. The strategic partnership is expected to fast-track the development and distribution of affordable, high-quality genetically engineered therapies across underserved markets in Africa and the Middle East. It will also focus on expanding Minapharm's licensing of proprietary technologies in monoclonal antibodies, cell and gene therapies, and vaccines—many of which have been incorporated into FDA-approved products. The collaboration includes plans to explore strategic acquisitions of global contract development and manufacturing organizations (CDMOs), further positioning Minapharm as a competitive force in the global biotech industry. Strategic Alignment and Regional Impact Dr. Wafik Bardissi, Chairman and CEO of Minapharm, welcomed the partnership, stating: 'With Admaius, we gain not only capital but a strategic partner whose insight, alignment, and ambition match our own. Together, we are advancing regional self-sufficiency and expanding the global reach of our innovations.' Admaius Capital Partners Managing Partner Marlon Chigwende described the deal as a 'landmark transaction,' adding: 'The founding families have built a unique asset on the African and European continents that combines scale, growth, and impact to fight cancer and other awful diseases.' Ahmed Rady, Managing Director at Admaius, praised the Minapharm team's scientific and operational capabilities: 'This partnership is about scaling a homegrown champion that combines cutting-edge global know-how with end-to-end manufacturing excellence.' Dr. Shaheer Bardissi, Co-CEO of Minapharm, emphasized the broader industry implications of the deal: 'This strategic collaboration with Admaius will accelerate and scale Minapharm's vision of translating cutting-edge scientific innovation into affordable therapies, while advancing global scientific frontiers in immunotherapy and advanced therapy medicinal products.' Advisory Teams Zilla Capital acted as the sole financial advisor to Triquera and existing shareholders, while legal counsel was provided by Matouk Bassiouny. Admaius Capital Partners was advised by White & Case LLP and commercial consultant Arthur D. Little.
CairoScene
28-07-2025
- CairoScene
Egyptian Student's Quantum Breakthrough Featured in Top Science Journa
Egyptian physicist Kerolos Mousa played a role in a Harvard breakthrough using metasurfaces to control light at the photon level, which may pave the way for major advances in quantum technologies. Jul 28, 2025 Kerolos Mousa, an Egyptian PhD student who hails from Minya, has contributed to a breakthrough in quantum physics at Harvard University, where a team of physicists developed a device capable of controlling the shape and path of individual photons with unprecedented precision. The innovation is based on metasurface technology, engineered materials that can manipulate electromagnetic waves, and represents a major advancement in the way light is handled within miniature optical environments. Mousa led efforts to design the nanostructures critical to regulating photon behaviour. The research, conducted at Harvard's Applied Physics Lab and supported by leading US scientific institutions, was published in Nature, a top US science journal, and Science, a leading British publications. It was also featured on the university's official channels. The advancement is hoped to significantly impact fields such as quantum communication, quantum computing, and the development of next-generation smart optical devices.
